On March 1, Dr. Todd Durham (Ph.D., Senior Vice President, Clinical & Outcomes Research, Foundation Fighting Blindness) will lead a dry AMD patient-focused drug development seminar. The online event is open to all (patients, families, professionals) and will include a panel of patients talking about their experiences with dry AMD. Volunteers for the panel are [Read More]
Author: Dan Roberts
Where Are We Now?
A Summary of the Past 30 Years of Low Vision Research and Development (An update presented to the International Low Vision Support Group by Director Dan Roberts) Macular Degeneration Support’s International Low Vision Support Group will soon celebrate its 30th year as a leading outreach to people affected by macular degeneration and other diseases leading [Read More]
First Human Eyeball Transplant Accomplished
Eye specialists at New York University Langone Health have announced success with the first transplantation of a complete human eyeball. High-voltage lineman Aaron James, 46, lost his eye in an electrocution accident on June 10, 2021. His multiple surgeries included a partial face transplant, during which the surgeons decided to also replace his eye. This [Read More]
Free Webinar: Therapeutic Targets for Dry AMD
David Boyer, M.D. – Therapeutic Targets for Dry AMD October 3, 2023 at 7:00 p.m. EDT Registration: https://bit.ly/45FfFdB The Foundation Fighting Blindness, the global leader in driving research for treatments and cures for blinding retinal diseases, will host a free webinar on Tuesday, October 3, 2023, from 7:00 – 8:00 p.m. ET. During the [Read More]
IZERVAY™, is the Second Treatment Approved by the FDA for Geographic Atrophy
IZERVAY™ reduced the rate of GA progression at the 12-month primary endpoint across two Phase 3 clinical trials. IZERVAY slowed loss of photoreceptors and disease progression as early as six months. Astellas Pharma Inc. announced on August 5, 2023 that the U.S. Food and Drug Administration (FDA) approved IZERVAY™ (avacincaptad pegol intravitreal solution) for the [Read More]